Key Industry Expert Speakers
9th Market Access, Pricing & Reimbursement Global Congress 2023 Europe
Trends and Strategies to Achieve Optimum Patient Access to Healthcare
4th - 5th May 2023 - Hilton London Kensington , London, UK
- Claudia Neuber, Head, Global Pricing Oncology, Global Market Access & Pricing, AstraZeneca
- Daniel Jackson, Global Head - Market Access Policy, UCB
- Maria Danchenko, Global Market Access Academy Lead, Sanofi
- Silvy Mardiguian, Market Access Director, UK & Ireland, BeiGene
- Marco Rauland, Vice President Global Market Access & Pricing - Strategic Planning, Merck Group
- Ana Plata, Global Pricing Head - BioPharmaceuticals, AstraZeneca
- Elvira Müller, Vice President, Certara Evidence & Access
- Santoke Naal, Director Market Access, IGES U.K. Pharma Ltd
- Rafael Souza, Ph.D Head of Access Solutions & Pricing, New Markets, BeiGene Switzerland GmbH
- Esther Nzenza, Founder and CEO, Decisive Consulting Ltd
- Vasiliki Patsioura, Global Pricing Implementation Lead, Astrazeneca
- Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation Poland
- Dr Alexander Natz, Secretary-General, EUCOPE
- Eugean Jiwanmall, Sr Research Analyst, Med. Policy & Tech Evaluation, Independence Blue Cross
- Maarten Van Baelen, Executive Director, Plasma Protein Therapeutics Association
- Marta Parmar, Head of International Regulatory Affairs, Alexion
- Ryotaro Ishikawa, Global Market Access Director, Novartis
- Jörg Mahlich, Market Access & Government Affairs Lead, Miltenyi Biomedicine
- Olga Katzelnik, Market Access Lead Europe/International, Regeneron
- Nazanin Mehin, Head of Global Diabetes Solutions, Sanofi
- Sara Lopes, Sr. Director, Global Market Access & Pricing Governance, Shionogi
- Andrew Stainthorpe, Head of Market Access, Oxford AHSN
- Marisca Marian, Oncology Market Access Strategy Leader, Bayer
- Jenniffer Cain Birkmose, VP, Global Head of Patient Access and Community Engagement, Sobi - Swedish Orphan Biovitrum AB*
- Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine
- Josie Godfrey, Co-Founder and CEO, Realise Advocacy
- David Bower, Principal, Head of Market Access Excellence, Clarion
- Libby Hamson, Senior Manager Market Access (mRNA Vaccines, Antivirals & Internal Medicines), Pfizer
